Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Title
Intervention Indication Therapeutic Area Year Actions
I-131-Apamistamab for acute myeloid leukaemia I-131-Apamistamab (Iomab-B) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2023 View  |  Download
Iomab-B for active, relapsed or refractory acute myeloid leukaemia in older patients (aged 55 years and older) I-131-Apamistamab (Iomab-B) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2017 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications